Ligand Pharmaceuticals, Inc. (LGND)
213.21
-5.77
(-2.63%)
USD |
NASDAQ |
May 15, 16:00
212.00
-1.21
(-0.57%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Liabilities (Quarterly) : 534.78M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| XOMA Royalty Corp. | 158.96M |
| Johnson & Johnson | 119.71B |
| Organon & Co. | 12.09B |
| Merck & Co., Inc. | 82.75B |
| Phathom Pharmaceuticals, Inc. | 642.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.532B |
| Shareholders Equity (Quarterly) | 997.32M |
| Debt to Equity Ratio | 0.4532 |
| Current Ratio | 21.28 |
| Net Debt Paydown Yield | -2.22% |